Professor, Institut Universitaire du Cancer de Toulouse-Oncopole, Toulouse, France

 

Jill Corre is a Professor at the Institut Universitaire du Cancer de Toulouse-Oncopole and a recognized expert in multiple myeloma biology and pharmacogenomics. She earned her PharmD and PhD from the Pharmaceutical Faculty of Tours and completed her residency in Medical Biology with a specialization in Hematology at the University Hospital of Toulouse.

​

Dr. Corre has been a member of the Hematology Laboratory at Toulouse University Hospital since 2007, where she has advanced to a professorship. Her doctoral work focused on the myeloma microenvironment, with particular emphasis on mesenchymal stromal cells and their role in disease progression.

​

In 2012, she joined the genomics research group led by Hervé Avet-Loiseau, contributing to pioneering work in myeloma genomics at the Toulouse Oncopole. Her current research is centered on pharmacogenomics of multiple myeloma within the Cancer Research Center of Toulouse, with a focus on understanding molecular drivers of disease and therapeutic response.

​

Dr. Corre is an active member of the Intergroupe Francophone du Myélome and the International Myeloma Society, and is widely recognized for her contributions to translational research in myeloma.